 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Current Price	$13.29
Prev Close	$13.15
Open	$13.20
Dividend Yield	N/A
50-Day Moving Average	$10.82
Beta	0.54
Avg. Volume	584,404.81
PE Ratio	-5.06

52-Week High	$13.60
52-Week Low	$2.32
Market Capitalization	$491.01M
EPS	-$2.62
Price to Book	2.71
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-1.30

AKUS Akouos Inc

About

Feed

Fundamentals

News